Actively Recruiting
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2025-09-24
15
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor
C
Conquer Cancer Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are conducting a qualitative observational study to assess how acceptable, appropriate, and feasible a new prognostic tool is for clinicians caring for patients with metastatic breast cancer. This tool aims to help identify patients at high risk of death within the next 30 days, with the goal of improving end-of-life care. The study will use interviews guided by implementation science theory to understand how to best integrate this tool into routine clinical practice. The study involves semi-structured interviews with healthcare providers such as physicians, nurse practitioners, physician assistants, and nurse navigators experienced in metastatic breast cancer care. These interviews will be conducted remotely by experienced qualitative researchers, using a flexible interview guide that evolves based on emerging themes. Data will be audio recorded and analyzed to identify barriers and facilitators to using the prognostic tool. Participants will engage in one interview via phone or secure videoconference, sharing their views and experiences. Researchers will evaluate key factors influencing the use of the tool and the discussion of prognosis between clinicians and patients over a 12-month period. The findings will help design an implementation approach to support the tool's adoption and improve patient-centered care for those with metastatic breast cancer.
CONDITIONS
Brief Title
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Verbal informed consent obtained to participate in the study
- Willing and able to comply with study procedures
- Physician, nurse practitioner, physician assistant, or nurse navigator
- At least 6 months of experience caring for metastatic breast cancer patients in the United States
You will not qualify if you...
- Non-English speaking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (remote or in-person)
Duration - Up to 12 months
Participants complete qualitative interviews conducted by researchers to assess the acceptability, appropriateness, and feasibility of a metastatic breast cancer-specific prognostic tool.
1 interview visit conducted via phone or secure videoconferencing
Trial Site Locations
Total: 1 location
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599
Actively Recruiting
Research Team
T
Terri Eubanks, BSBA
E
Erin Kelly, MPH, RD, LDN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here